Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis
- PMID: 20004120
- DOI: 10.1016/j.ejvs.2009.11.013
Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis
Abstract
Objectives/design: In symptomatic patients treated with ipsilateral carotid artery stenting (CAS) plus intensive lipid lowering, we assessed the changes of osteopontin (OPN), osteoprotegerin (OPG) and the Gray-Scale Median (GSM) score contralateral to symptomatic carotid stenosis.
Materials/methods: Forty-six symptomatic patients (group A) with significant carotid stenosis (North American Symptomatic Carotid Endarterectomy Trial (NASCET): >70%) underwent ipsilateral CAS. Those patients had simultaneously contralateral low-grade carotid stenosis (NASCET: 30-69%). Group B included 67 symptomatic patients with low-grade bilateral carotid stenosis (NASCET: 30-69%), but without indications for revascularisation. All patients were treated with atorvastatin (10-80mg) to target low-density lipoprotein (LDL)<100mgdl(-1). Blood samples and plaques' GSM score contralateral to brain infarct were assayed at baseline and after 6 months.
Results: At baseline, there were no significant differences between groups (p>0.05). Six-month atorvastatin treatment equivalently improved lipid profile in both groups (p<0.05). The parameters hsCRP, OPN and OPG were significantly down-regulated within both groups, but to a greater extent in group A (p<0.05). Besides this, contralateral GSM score was significantly improved from baseline in both groups (p<0.01), but that increment was more pronounced in group A (vs. group B; p=0.041). These changes were inversely correlated with changes in OPN (p=0.014), OPG (p=0.011) and LDL (p=0.041).
Conclusion: Ipsilateral CAS plus intensive lipid-lowering therapy was associated with enhanced contralateral carotid plaque stability and attenuated inflammatory burden and calcification inhibitors to a greater extent than atorvastatin therapy alone in patients with bilateral carotid stenosis.
Copyright 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.J Vasc Surg. 2010 Jan;51(1):114-21. doi: 10.1016/j.jvs.2009.07.119. Epub 2009 Oct 17. J Vasc Surg. 2010. PMID: 19837545 Clinical Trial.
-
Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.Eur J Vasc Endovasc Surg. 2008 Jun;35(6):661-8. doi: 10.1016/j.ejvs.2007.12.011. Epub 2008 Apr 18. Eur J Vasc Endovasc Surg. 2008. PMID: 18395477 Clinical Trial.
-
The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.J Vasc Surg. 2008 Jan;47(1):55-62. doi: 10.1016/j.jvs.2007.09.058. J Vasc Surg. 2008. PMID: 18178454
-
Endarterectomy or carotid artery stenting: the quest continues.Am J Surg. 2008 Feb;195(2):259-69. doi: 10.1016/j.amjsurg.2007.07.022. Am J Surg. 2008. PMID: 18154764 Review.
-
Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.Am J Cardiol. 2005 Sep 5;96(5A):61F-68F. doi: 10.1016/j.amjcard.2005.07.013. Am J Cardiol. 2005. PMID: 16126025 Review.
Cited by
-
Ultrasound assessment of carotid plaque echogenicity response to statin therapy: a systematic review and meta-analysis.Int J Mol Sci. 2015 May 12;16(5):10734-47. doi: 10.3390/ijms160510734. Int J Mol Sci. 2015. PMID: 25984600 Free PMC article.
-
Neural repair function of osteopontin in stroke and stroke‑related diseases (Review).Exp Ther Med. 2024 Oct 16;28(6):459. doi: 10.3892/etm.2024.12749. eCollection 2024 Dec. Exp Ther Med. 2024. PMID: 39478739 Free PMC article. Review.
-
Serum levels of fetuin-A, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy.Clin Drug Investig. 2014 Mar;34(3):165-71. doi: 10.1007/s40261-013-0157-y. Clin Drug Investig. 2014. PMID: 24307429
-
The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review.Rev Cardiovasc Med. 2024 Jan 30;25(2):51. doi: 10.31083/j.rcm2502051. eCollection 2024 Feb. Rev Cardiovasc Med. 2024. PMID: 39077343 Free PMC article. Review.
-
The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)-A Narrative Review.Biomedicines. 2023 Nov 29;11(12):3178. doi: 10.3390/biomedicines11123178. Biomedicines. 2023. PMID: 38137398 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous